Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations

RecruitingOBSERVATIONAL
Enrollment

2,100

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Pancreatic Ductal AdenocarcinomaPancreatic DiseasesPancreatic Elastase 1Pancreatic Neuroendocrine TumorPancreatitisPancreatic Neoplasms
Interventions
DIAGNOSTIC_TEST

Pancreatic elastase-1 in blood serum

Serum samples were collected from each patient to detect serum multiomics and pancreatic elastase-1 (PE-1). We examine multiomics in the pancreatic tissue collected from the patient who had undergone surgery or the necessary puncture examination and signed the informed consent form.

Trial Locations (1)

250063

RECRUITING

Ning Zhong, Jinan

All Listed Sponsors
collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

First Affiliated Hospital of Guangxi Medical University

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

LanZhou University

OTHER

lead

Qilu Hospital of Shandong University

OTHER